AnirbanMitraMDPhD

Urology • Los Angeles, CA

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncologist, Cedars-Sinai Medical Center

Join to view full profile

Dr. Mitra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mitra's full profile

Already have an account?

Office
8635 W Third St
Ste 1070W
Los Angeles, CA 90048
Phone+1 310-423-4700

Fax+1 310-423-4711

Summary

Anirban P. Mitra, MD, PhD, is a board-certified urologist and urologic oncologist at the Cedars-Sinai Urology Academic Practice. He is an Assistant Professor in the Departments of Urology and Computational Biomedicine at Cedars-Sinai Medical Center. Dr. Mitra's clinical practice includes treatment of cancers of the bladder, kidney, prostate, urethra, upper urinary tract, testis, penis and adrenal glands. He is fellowship-trained in the management of urologic malignancies, with expertise in complex open and minimally invasive (laparoscopic and robotic) surgery.

Dr. Mitra's clinical work informs and directs his scientific interests. His research portfolio encompasses studies investigating clinicopathologic and molecular drivers of progression and therapeutic response of genitourinary tumors, with emphasis on urinary bladder cancer. His work has involved multidisciplinary collaborations, multicenter investigations and clinical trials, with an overarching goal of identifying optimal oncologic management strategies. His research has been published in high-impact journals and has been widely referenced. He has served on international advisory committees for urologic cancers and is on the editorial board for several journals.

Education & Training

KJ Somaiya Medical CollegeClass of 2002, Top 5% of graduating class
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology
University of Southern CaliforniaPhD, Pathobiology, J. Watumull Scholarship; Best PhD student

Certifications & Licensure

TX State Medical License 2020 - 2026
CA State Medical License 2017 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

Invited Committee Member, International Consultation on Molecular Biomarkers in Urologic Oncology International Consultation on Urologic Diseases (ICUD), World Urologic Oncology Federation (WUOF), Société Internationale d'Urologie (SIU)
Arnold Heyman Scholarship Institute of Urology, University of Southern California
Marquis Who's Who in the World
Invited Committee Member, International Consultation on Bladder Cancer Société Internationale d'Urologie (SIU), International Consultation on Urologic Diseases (ICUD)
Joseph F McCarthy Physician Essay Award Western Section of the American Urological Association
John Quale Travel Fellowship Bladder Cancer Advocacy Network
Urologic Oncology Travel Award American Urological Association
ASCO Merit Award Conquer Cancer Foundation of the American Society of Clinical Oncology
Best Poster American Urological Association
James L Goebel Award Western Section of the American Urological Association
Elected Officer, Associate Member Council American Association for Cancer Research
Member of the Order of Areté, Outstanding Graduate Student Recognition University of Southern California
International Student Academic Achievement Award University of Southern California
Outstanding Clinical Scholar Award American Association for Cancer Research
Phi Kappa Phi National Honor Society
Scholar-in-Training Award American Association for Cancer Research
Join now to see all

Publications & Presentations

PubMed

Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study.
Alireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, Ashish Khanna, Amitabh Singh
European Urology Focus. 2024-11-16
Biomarkers of treatment response in bladder cancer.
John R Heard, Michael Ahdoot, Dan Theodorescu, Anirban P Mitra
Expert Review of Molecular Diagnostics. 2024-10-01
Editorial Comment.
Anirban P Mitra
The Journal of Urology. 2024-02-01

Books/Book Chapters

Precision Molecular Pathology of Bladder Cancer
Chapter: Risk factors and molecular features associated with bladder cancer development.
Page 3 - 28Mitra AP, Bartsch G Jr, Cote RJEditors: Hansel DE, Lerner SP.Springer Nature, Cham, Switzerland2018
Bladder Cancer: A Joint SIU-ICUD International Consultation
Chapter: Molecular markers
Page 285 - 371Shariat SF, Lotan Y, Dobruch J, Gust KM, Inman BA, Krabbe LM, Mitra AP, Soria F, Todenhöfer TEditors: Black P, Gontero P.Société Internationale d’Urologie, Montréal, Canada2018
Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management
Chapter: Novel molecular and genotype profiling in prostate cancer: the future of screening, diagnosis, and staging.
Page 77 - 83Shin H, Vergara IA, Mitra AP, Triche TJ, Davicioni EEditors: Dicker AP, Kelly WK, Zaorsky NG, Trabulsi EJ.Demos Medical, New York, NY2015
The SAGE Encyclopedia of Cancer and Society
Chapter: Bladder cancer
Page 148 - 149Mitra APEditors: Colditz GA.Sage Publications, Thousand Oaks, CAEdition 2,2015
Advances in Bladder Cancer Management
Chapter: Molecular markers for screening, detection and prognosis of bladder cancer.
Page 62 - 88Xylinas E, Mitra AP, Daneshmand S, Shariat SFEditors: Xylinas E, Shariat SF.Future Medicine, London, UK2015
Comprehensive Textbook of Genitourinary Oncology
Chapter: Molecular biology and prognostic markers in bladder cancer.
Page 317 - 333Mitra AP, Theodorescu D, Lerner SP, Cote RJ, Datar RHEditors: Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, Sheinfeld J, Rini BI, Bochner BH.Lippincott Williams & Wilkins, Philadelphia, PAEdition 4,2011
Modern Surgical Pathology
Chapter: Bladder and urethra.
Page 1079 - 1120Cote RJ, Mitra AP, Amin MBEditors: Weidner N, Cote RJ, Suster S, Weiss LM.Saunders, Philadelphia, PAEdition 2,2009
Join now to see all

Authored Content

Molecular biology of bladder cancer.February 2020
US Patent # 8293880 - Prognostic panel for urinary bladder cancer.October 2012
Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder.July 2009

Press Mentions

Pre-cystectomy smoking linked to worse outcomes after surgery.May 1st, 2020
Prolonged surgical delay increases bladder cancer recurrence risk.May 1st, 2020
Smoking intensity and cancer markers predict seriousness of bladder cancer.May 1st, 2020
Join now to see all